Baker Hughes offers remedies to obtain EU nod for Chart deal - Finance news and analysis from Global Banking & Finance Review
Finance

Baker Hughes offers remedies to obtain EU nod for Chart deal

Published by Global Banking & Finance Review

Posted on June 22, 2026

2 min read

· Last updated: June 22, 2026

Add as preferred source on Google

Baker Hughes Proposes Remedies to Secure EU Approval for Chart Industries Deal

Overview of the Baker Hughes and Chart Industries Acquisition

Introduction to the Proposed Acquisition

BRUSSELS, June 22 (Reuters) - U.S. oilfield services ‌firm Baker Hughes has offered remedies in an effort to secure EU antitrust approval for its $13.6 billion acquisition of Chart Industries, a European Commission filing showed on Monday.

European Commission's Review Process

The Commission, which acts as the European Union's competition enforcer, did not provide details of the proposed remedies, in line with its policy. It set a July 10 deadline for its decision.

Potential Outcomes of the Review

It will likely seek feedback from clients and rivals of the two companies before deciding whether to accept the remedies, demand more or open a full-scale four-month-long investigation if it has serious concerns.

Strategic Rationale Behind the Deal

Baker Hughes announced the ​deal in July last year ⁠to reinforce its presence in ​industrial technology servicing liquefied natural ​gas and data centres and to leverage its industrial and energy technology portfolio.

About Chart Industries

Chart makes ​industrial equipment such as valves ​and ⁠measurement technology for gas and liquid molecule handling and has ⁠65 ​manufacturing locations with ​more than 50 service centres globally.

Global Reach and Capabilities

(Reporting by Foo Yun Chee, editing by Milla Nissi-Prussak)

Key Takeaways

  • Deal values Chart Industries at $13.6 billion, with Baker Hughes offering $210 per share in cash and expecting mid‑2026 close, subject to regulatory and shareholder approvals. (jpt.spe.org)
  • The European Commission’s preliminary Phase I review began in late May and originally set a June 26 deadline, but recent filings now indicate a July 10 decision window. (pymnts.com)
  • Depending on its assessment, the Commission may accept the remedies, request further concessions, or initiate a full-scale Phase II investigation if serious competition concerns arise. (marketscreener.com)

References

Frequently Asked Questions

What is the value of Baker Hughes's acquisition of Chart Industries?
Baker Hughes's acquisition of Chart Industries is valued at $13.6 billion.
Why has Baker Hughes offered remedies to the European Commission?
Baker Hughes has offered remedies to address EU antitrust concerns and secure approval for the acquisition.
When is the EU expected to decide on the Baker Hughes-Chart deal?
The European Commission has set a July 10 deadline to make its decision.
What does Chart Industries specialize in?
Chart Industries manufactures industrial equipment like valves and measurement technology for gas and liquids.
What could happen if the EU has serious concerns about the deal?
The EU could demand more remedies or open a full-scale investigation lasting four months.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category